Latest Research News

A digital cognitive behavioral therapy (CBT) program was more effective than clinician-delivered cognitive behavioral therapy in increasing alcohol abstinence in patients over an 8-month study period, according to a new Yale study. Brian D. Kiluk, PhD, associate professor of psychiatry, is lead author of the study, published in JAMA Network Open.

Investigators in the Yale Department of Psychiatry investigated the genetic profiles of more than 1 million participants enrolled in multiple cohorts around the world. Leveraging this large dataset, they uncovered more than 100 genes associated with anxiety. Eleni Friligkou, MD, MSc, and Renato Polimanti, PhD, MSc, are first and senior authors, respectively.

A new study, led by researchers at Yale School of Medicine and the Veterans Affairs National Center for PTSD, utilized positron emission tomography imaging with [11C]PBR28, a radiotracer to measure 18-kDa translocator protein to better understand microglia, the resident immune cells in the brain of individuals with PTSD.

Bao-Zhu Yang, PhD, research scientist in psychiatry, has been awarded a grant by the National Institute on Drug Abuse for a study related to drug use and HIV.

In a study published in JAMA, Yale scientists found that tobacco companies have begun to market products thatcontain nicotine analogs that mimic highly addictive nicotine.

New research led by three Yale School of Medicine scientists aims to achieve better understanding of the molecular effects of alcohol use disorder (AUD) on certain regions of the brain.

As many as four out of every 10 teenagers and young adults who vape are modifying their e-cigarettes in ways that could expose them to burns, lung injury, and covert use of marijuana, a team of Yale Department of Psychiatry scientists found.

VA Connecticut Healthcare Center and Yale School of Medicine researchers have completed the first well-powered, genome-wide association study of epiretinal membrane, a common retinal disorder that often causes visual distortion or loss of visual acuity. The first author was Joel Gelernter, MD. Co-author was Daniel Levey, PhD.

Marek Chawarski, PhD, professor of psychiatry and emergency medicine, is senior author of a study in Natural Product Research that explains observed differences in the safety profiles of kratom fresh-leaf preparations consumed in Southeast Asia with highly processed and oxidated products labelled “kratom” primarily consumed in the United States and other countries.